| (210) | Number of the EPO application | 19745925 |
| (220) | Filing date of the EPO application | 2019.07.11 |
| (80) | EPO patent specification publication (B) | EPB nr. 47/2022, 2022.11.23 |
| (110) | EPO patent number | 3820873 |
| (11) | Number of the document | MD 3820873 T2 |
| (21) | Number of the application | e 2021 0462 |
| (71) | Name(s) of applicant(s), code of the country | ELI LILLY AND COMPANY, US; |
| (72) | Name(s) of inventor(s), code of the country | BASTIAN Jolie Anne, US;
COHEN Jeffrey Daniel, US;
RUBIO Almudena, US;
SALL Daniel Jon, US;
MCMAHON Jennifer Anne, US; |
| (73) | Name(s) of owner(s), code of the country | ELI LILLY AND COMPANY, US; |
| (54) | Title of the invention | Selective estrogen receptor degraders |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 491/052 (2006.01.01); A61K 31/436 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.06.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.05.31 |
| (30) | Priority | 201862697100 P, 2018.07.12, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2019/041334, 2019.07.11 |
| (87) | International publication | WO 2020/014435, 2020.01.16 |